Loxo Oncology Inc.
Process for the preparation of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6- -diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-car- bontrile
Last updated:
Abstract:
In some embodiments, provided herein is a process for preparing a compound of Formula I ##STR00001## or a pharmaceutically acceptable salt thereof, as disclosed herein.
Status:
Grant
Type:
Utility
Filling date:
16 Jun 2020
Issue date:
24 Aug 2021